poisar

Stock

Cardinal Health, Inc. CAH

$232.31+0.46%

Overview

CAH market data

Price History

CAH price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
34.65
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$6.45
Diluted earnings per share over the trailing twelve months.
Beta
0.49
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
0.9%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
0.6%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$145.47 – $258.30
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $53.9B · P/B 9.25 · P/S 0.21.

Company News

10 captured
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280Benzinga · Aug 13, 2026, 4:40 PM
JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260Benzinga · Aug 13, 2026, 3:00 PM
Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275Benzinga · Aug 13, 2026, 2:02 PM
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270Benzinga · Aug 12, 2026, 4:06 PM
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265Benzinga · Aug 12, 2026, 3:50 PM
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250Benzinga · Aug 12, 2026, 1:50 PM
UBS Maintains Buy on Cardinal Health, Raises Price Target to $280Benzinga · Aug 12, 2026, 1:13 PM
Cardinal Health Analysts Increase Their Forecasts Following Q4 ResultsBenzinga · Aug 12, 2026, 12:28 PM
Wells Fargo Maintains Overweight on Cardinal Health, Raises Price Target to $277Benzinga · Aug 12, 2026, 12:20 PM
Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274Benzinga · Aug 12, 2026, 10:28 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock